Selling And Administration Expenses 更改
AbbVie USD 3.25B 40M 2025-06
Cipla INR 13.12B 792M 2025-06
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.37M 361K 2024-12
CSL USD 1.18B 201M 2024-12
Grifols EUR 269.48M 49.95M 2024-12
Novo Nordisk DKK 16.11B 480M 2025-03
Pfizer USD 3.42B 406M 2025-06


TherapeuticsMD 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.